White House Reveals Privacy and Trust Principles for Precision Medicine Initiative

As part of its Precision Medicine Initiative (PMI) announced in January 2015, the White House’s interagency agency working group has developed privacy and trust principles for activities within the agenda.
Nov. 13, 2015
2 min read

As part of its Precision Medicine Initiative (PMI) announced in January 2015, the White House’s interagency agency working group has developed privacy and trust principles for activities within the agenda.

The initiative’s aim, per President Barack Obama’s announcement earlier this year, is to pioneer a new model of patient-powered research to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select which treatments will work best for which patients.

According to a White House statement, the recrntly-developed principles provide broad guidance for future PMI activities regarding: governance; transparency; participant empowerment; respect for participant preferences; data sharing, access, and use; and data quality and integrity. “The principles articulate a set of core values and responsible strategies for sustaining public trust and maximizing the benefits of precision medicine,” it says.

The privacy and trust principles were developed by an interagency working group that was co-led by the White House Office of Science and Technology Policy, the Department of Health and Human Services’ Office for Civil Rights, and the National Institutes of Health. The principles were developed after and were informed by series of expert roundtables, review of the bioethics literature, an analysis of privacy policies and frameworks used by existing biobanks and large research cohorts, and comment from the public, according to the White House.

What’s more, PMI is taking steps to build security practices into the development of the initiative to ensure the confidentiality and integrity of all PMI data. The security policy framework will draw on  best practices in identifying strong administrative, technical, and physical safeguards to  ensure the confidentiality and integrity of all PMI cohort specimens and data, and will be reevaluated regularly to keep pace with an ever-advancing technological environment , the White House says.

The privacy and trust principles can be read in their entirety here.

About the Author

Rajiv Leventhal

Rajiv Leventhal

Managing Editor

Rajiv Leventhal is Managing Editor of Healthcare Innovation, covering healthcare IT leadership and strategy. Since 2012, he has been covering health IT developments for the publication's CIO and CMIO-based audience, and has taken keen interest in areas such as policy and payment, patient engagement, health information exchange, mobile health, healthcare data security, and telemedicine.

He can be followed on Twitter @RajivLeventhal

Sign up for our eNewsletters
Get the latest news and updates